5-hydroxymethylcytosine: a potential therapeutic target in cancer

Area of Science:

• Epigenetics
• Molecular Biology
• Cancer Research

Background:

• 5-methylcytosine is converted to 5-hydroxymethylcytosine by ten-eleven translocation (TET) enzymes.
• 5-hydroxymethylcytosine is a key epigenetic mark involved in active DNA demethylation.
• Dysregulated methylation patterns are implicated in various human diseases, particularly cancer.

Purpose of the Study:

• To provide an overview of the 5-hydroxymethylcytosine pathway's role in human disease.
• To discuss novel techniques for high-resolution mapping of 5-hydroxymethylcytosine distribution.
• To propose therapeutic strategies targeting the 5-hydroxymethylcytosine pathway in cancer.

Main Methods:

• Literature review of the 5-hydroxymethylcytosine pathway in disease.
• Discussion of emerging high-resolution mapping techniques for 5-hydroxymethylcytosine.
• Analysis of recent functional studies and current epigenetic therapies.

Main Results:

• The 5-hydroxymethylcytosine pathway plays a significant role in human diseases, including cancer.
• Innovative techniques enable high-resolution mapping of 5-hydroxymethylcytosine distribution.
• Targeting the 5-hydroxymethylcytosine pathway presents potential therapeutic avenues for cancer.

Conclusions:

• The 5-hydroxymethylcytosine pathway is a promising target for cancer therapy.
• Further research is needed to fully elucidate the role and therapeutic potential of 5-hydroxymethylcytosine.
• High-resolution mapping techniques will advance our understanding of this epigenetic mark.